India Curbs Exports Amid Coronavirus
Restricted Products Include Paracetamol API And Formulations
Executive Summary
India has published a list of APIs and formulations for which exports will be restricted, with immediate effect. The move comes against the backdrop of growing concerns over the off-patent industry’s supply chain given the ongoing pressures caused by the coronavirus outbreak.
You may also be interested in...
Challenges Remain For Off-Patent Industry’s COVID Response
At an symposium convened by the WHO, WIPO and WTO, the IGBA has highlighted ongoing challenges for the off-patent industry’s continuing response to the COVID-19 pandemic.
‘Critical To Bring Back Domestic Manufacturing Of Key Essentials’ Insists Phlow CEO
In an exclusive interview with Generics Bulletin, Phlow Corp CEO Eric Edwards has criticized the growing list of drug shortages in the US. He outlined the government-backed company’s objective of tackling drug shortages and supply chain vulnerabilities, to create a national stockpile of essential medicines.
Indoco Sees Profits Double
After reporting a loss after tax last year, India’s Indoco has recovered and reported a substantial post-tax profit, as well as operating profit that doubled in its latest financial year, despite battling supply chain issues caused by the coronavirus crisis.